The downgrade follows a 24% rise in BioNTech’s shares to $113 from December lows of $92, a move that outpaced the 4% gain in the S&P Biotechnology Select Industry Index over the same period. Leerink ...

BioNTech (NasdaqGS:BNTX) has appointed Kylie Jimenez as Chief People Officer. The new executive role is designed to support BioNTech's goal of becoming a multi product oncology company by 2030. This ...

BioNTech has initiated a Phase III clinical trial for its oncology candidate BNT324 in metastatic castration-resistant prostate cancer, aiming to compare the drug against current standard chemotherapy ...

After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.

Pfizer Inc (PFE) announced an update on their ongoing clinical study. modRNA shingles pursuit from Pfizer and BioNTech now centers on the terminated Phase 1/2 study formally titled “A PHASE 1/2 ...

BioNTech SE (F:22UAy) (NASDAQ:BNTX) has been downgraded to “market perform” from “outperform” by Leerink Partners after a ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") announced today that the Supervisory Board has appointed Kylie Jimenez to the Management Board ...

We came across a bullish thesis on BioNTech SE on Lux Opes Research’s Substack. In this article, we will summarize the bulls’ thesis on BNTX. BioNTech SE’s share was trading at $118.00 as of January ...

German biotech BioNTech today announced that the US Food and Drug Administration (FDA) has granted fast track designation to BNT113, an investigational mRNA cancer immunotherapy, for the treatment of ...

PHILADELPHIA--(BUSINESS WIRE)--The University of Pennsylvania (“Penn”), BioNTech SE (“BioNTech”), and OUP (Osage University Partners) announced the launch of the $50 million Penn-BioNTech Innovative ...

BioNTech SE (NASDAQ:BNTX) Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, expectations were $0.75. Operator: Welcome to ...